Crossmark

Comparison of allo-SCT versus consolidation chemotherapy as post-remission therapy in acute lymphoblastic leukaemia aged ≥55 years

Crossref DOI link: https://doi.org/10.1038/s41409-024-02448-3

Published Online: 2024-10-21

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Ling

Ma, Rui

Jiang, Qian https://orcid.org/0000-0001-7131-0522
Jiang, Hao

Zhang, Xiao-Hui https://orcid.org/0000-0003-0245-6792
Xu, Lan-Ping https://orcid.org/0000-0002-0267-1081
Wang, Yu https://orcid.org/0000-0003-1253-7465
Mo, Xiao-Dong https://orcid.org/0000-0002-9881-7945
Lv, Meng

Huang, Xiao-Jun https://orcid.org/0000-0002-2145-6643
Sun, Yu-Qian https://orcid.org/0000-0003-1856-2231
License Information

Text and Data Mining valid from 2024-10-21

Version of Record valid from 2024-10-21
More Information

Article History

Received: 17 July 2024

Revised: 13 October 2024

Accepted: 15 October 2024

First Online: 21 October 2024

Competing interests

: The authors declare no competing interests.